Barroso-Sousa R, Krop IE, Trippa L, Tan-Wasielewski Z, et al. A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer. Clin Breast Cancer 2020 Jan 30. pii: S1526-8209(20)30028.
PMID: 32113750